|
|
by Claremont Creek Alerts on January 18th, 2012 
January 18, 2012 source: MedCity News
Personalized medicine company AssureRx Health has released the next-generation version of its genetic screening test for psychiatric drugs.
The Cincinnati-area company’s GeneSightRx test, which helps doctors pick the right psychiatric drugs for patients based on their genes, was launched in 2009. The test uses a cheek swab, mathematical algorithms and bioinformatics to narrow drug choices to those that work with a patient’s genes.
. . .
→ Read full post: Claremont Creek Ventures’ portfolio company AssureRX updates its psychiatric drugs screening test
by Claremont Creek Alerts on December 15th, 2011 
September 9, 2011 source: originally published in the San Francisco Business Times
Photo: Spencer Brown The winner “is the company that’s going to help families,” says GSN CEO Rabinowitz.
Gene Security Network’s race to develop safer, more accurate prenatal test is all business for Matt Rabinowitz — and it’s personal.
A relative of Rabinowitz, Gene Security Network’s CEO, took a blood test for the likelihood of Down’s syndrome in her unborn baby and . . .
→ Read full post: Claremont Creek Ventures’ portfolio company Gene Security Network in race for prenatal test
by Claremont Creek Alerts on September 12th, 2011 
Berger joins as Associate; Lyons joins as Entrepreneur-In-Residence (EIR)
Claremont Creek Ventures, a seed and early-stage venture capital firm known for turbocharging the uncommon startup, today announced the addition of two investment professionals who have impressive experience either in the medical sector or in product leadership at early-stage cleantech innovators.
Brian Berger, MD, 41, joins Claremont Creek Venture’s digital healthcare investment team as an associate to invest in new healthcare startups combining advances in information technology . . .
→ Read full post: Claremont Creek Ventures adds Brian Berger, MD and former IDEO executive and Tesla Head of Engineering, Dave Lyons to investment team
by Brad Webb on July 6th, 2011 July 1, 2011 source: Genetic Engineering & Biotechnology News by Brad Webb
Rapid Transition from Laboratory Discoveries to Commercialization Is Transforming Healthcare
It’s been less than a decade since a full human genome was sequenced, but already there is talk that the promise of genomics-inspired personal medicine is not being realized. I couldn’t disagree more. As we point out in this article, cardiologists, psychiatrists, and internists can now order quick and inexpensive genetics-based screening . . .
→ Read full post: Moving Quickly from an Idea to a Product
May 11, 2011 source: Wall Street Journal Health Blog
Public Education and Gene Testing to Improve Medication Adherence
There are tons of reasons why people don’t take the medications they’ve been prescribed, including side effects, cost and complicated drug regimens.
A couple of different approaches to improving adherence are in the news today. The first is Script Your Future, a multi-year public-education campaign spearheaded by the National Consumers League and supported by health-industry companies, . . .
→ Read full post: Claremont Creek Ventures portfolio company AssureRx featured in WSJ article
by Claremont Creek Alerts on April 6th, 2011 April 5, 2011 source: Gene Security Network press release
Gene Security Network (GSN) welcomes the birth of the first baby to be born following the use of GSN’s novel Parental SupportTM technology for single gene preimplantation genetic diagnosis (PGD) and concurrent 24-chromosome screening. This test allows couples who are at risk to have children with genetic disease to undergo embryo testing during an in vitro fertilization (IVF) cycle in order to . . .
→ Read full post: Claremont Creek Ventures portfolio company GSN’s testing technology helps couple achieve their dream of a healthy child
by Claremont Creek Alerts on March 25th, 2011 March 25, 2011 source: VentureWire by Timothy Hay
AssureRx Health Inc. has raised an $11 million Series B round from Sequoia Capital and Claremont Creek Ventures for its testing system that helps psychiatric patients find the most compatible medications, according to an investor.
“This could be one of the biggest diagnostic companies of the decade, in my estimation,” said John Steuart, a Claremont Creek co-founder and managing director who takes . . .
→ Read full post: AssureRx Pulls Together $11M For Psych Diagnostics
by Claremont Creek Alerts on March 25th, 2011 
- Personalized Medicine Company to Expand Marketing and Product Development for Neuropsychiatric Pharmacogenetics -
CINCINNATI, March 25, 2011 – AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric patients, will use the funds to expand direct sales and marketing for its first product, GeneSightRx®, and for . . .
→ Read full post: Claremont Creek Ventures portfolio company AssureRx Health raises $11 Million Series B financing
by Claremont Creek Alerts on November 3rd, 2010 November 1, 2010 source: Gene Security Network (download the pdf press release)
REDWOOD CITY, CA – November 1, 2010 – Gene Security Network, Inc. (GSN) today announced the closing of its $12M Series C financing. The financing round was led by Sequoia Capital and included Claremont Creek Ventures, Founders Fund, and Lightspeed Venture Partners.
GSN is a molecular diagnostics company using data informatics to enhance genetic testing of DNA. . . .
→ Read full post: Gene Security Network Completes Funding to Expand Into New DNA Testing Markets
by Claremont Creek Alerts on August 11th, 2010 August 10, 2010 source: Send2Press Newswire DAVIS, Calif., Aug. 10 (SEND2PRESS NEWSWIRE) — California IVF: Davis Fertility Center, Inc. (californiaivf.com), working in conjunction with Gene Security Network (genesecurity.net) leads the field in bringing a new test to patients that combines the detection of single-gene genetic disorders with a 24 chromosome screening. Using Gene Security Network’s Parental Support™ technology, at-risk couples undergoing in vitro fertilization can now test developing embryos for a larger number . . .
→ Read full post: Fertility Patients Can Now Use One Screening for Multiple Types of Genetic Diseases Before Pregnancy
|
